Boston Scientific completes sale of auditory business and drug pump development program
Boston Scientific Corporation today announced that it has completed the sale of the controlling interests in its auditory business and drug pump development program to former principals and shareholders of Advanced Bionics.
Boston Scientific Corp. announced Monday that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to the Getinge Group of Sweden for $750 million in cash.